Annexin V Kit

100% Secure

Annexin V Assay Kit - 300 Tests thumbnail image 1

Annexin V Assay Kit - 300 Tests thumbnail image 2

Annexin V Assay Kit - 300 Tests thumbnail image 3

Annexin V Assay Kit - 300 Tests gallery image 1 — Jurkat cells were treated as shown with staurosporine at 1 μM to induce apoptosis. The cells were then stained with annexin V FITC (ANNEX300F) and ReadiDrop™ propidium iodide (1351101). Apoptotic cells positive for annexin V can be seen in the bottom right quadrant and dead cells positive for both annexin and PI in the top right quadrant. Healthy cells are negative for both stains. Data acquired on the ZE5™ Cell Analyzer.

Annexin V Assay Kit - 300 Tests gallery image 2 — Jurkat cells were treated as shown with staurosporine at 1 μM to induce apoptosis. The cells were then stained with annexin V FITC (ANNEX300F) and ReadiDrop™ propidium iodide (1351101). Apoptotic cells positive for Annexin V can be seen in the bottom right quadrant and dead cells positive for both Annexin and PI in the top right quadrant. Healthy cells are negative for both stains.

Annexin V Assay Kit - 300 Tests gallery image 3 — **Published customer image:**
Annexin V:FITC Assay Kit used for cell cycle analysis of cells treated with Arsenic trioxide and *Macuna macrocarpa* extract by flow cytometry.
**Image caption:**
Annexin V-FITC/propidium iodide (PI) analyses of arsenic trioxide (ATO)- and/or crude methanolic extract of *Mucuna macrocarpa* (CMEMM)-treated cells. HL-60 (a) and Jurkat (b) cells (1 × 10⁵ cells/mL) were first treated with 5 mM N-acetyl cysteine (NAC), 50 μM butylated hydroxytoluene (BHT), or 40 μM α-tocopherol (VitE) or untreated, followed by treatment with 0.1% DMSO (CTL), 2.5 μM ATO, and/or 50 μg/mL CMEMM as indicated for 24 h. Quantitative percentages of apoptotic cells of ATO/CMEMM-treated cells were measured by flow cytometry. Data represent the result from one of three independent experiments.

From: Lu KH, Lee HJ, Huang ML, Lai SC, Ho YL, Chang YS, Chi CW. Synergistic Apoptosis-Inducing Antileukemic Effects of Arsenic Trioxide and *Mucuna macrocarpa* Stem Extract in Human Leukemic Cells via a Reactive Oxygen Species-Dependent Mechanism.
Evid Based Complement Alternat Med. 2012;2012:921430.

Annexin V:FITC Assay Kit

Product Type: Kits

Product Code	Applications	Pack Size	Your Price	List Price	Quantity
ANNEX300F Datasheet	F SDS	300 Tests	Log in		Get Quote

This test employs the property of Annexin V to bind to the membrane phospholipid phosphatidylserine (PS) in the presence of Ca²⁺. PS is exposed at the cell surface during the early stages of apoptosis. Detection of PS is a very sensitive method for detecting cells entering apoptosis, at a time point considerably ahead of nuclear changes such as DNA degradation.

The conjugation protocol used to prepare this product has not changed the native phospholipid binding properties of Annexin V. This protocol is designed to measure apoptosis easily and quickly in a sample of suspended cells.

View our complete list of formats and sizes of Annexin V kits

Product Details

Buffer Solution

Annexin V:FITC:
TRIS Buffered saline

Binding Buffer (after dilution):
10mM Hepes/NaOH
140mM NaCl
2.5mM CaCl₂

Preservative Stabilisers

Annexin V:FITC:
0.02% Sodium Azide (NaN₃)
1% Bovine Serum Albumin

Reagents in the Kit

Annexin V:FITC	1x 1.5 ml vial
Propidium Iodide	2x 1.8 ml vial at 20 ug/ml
Binding Buffer	1x 50 ml vial (4x concentrate)

Storage Information

Storage: Store at +4^oC. DO NOT FREEZE
This product is photosensitive and should be protected from light.
Guarantee: Guaranteed until date of expiry. Please see product label.

More Information

UniProt: P08758
Entrez Gene: ANXA5
GO Terms: GO:0005509 calcium ion binding; GO:0007596 blood coagulation; GO:0004859 phospholipase inhibitor activity; GO:0007165 signal transduction; GO:0005544 calcium-dependent phospholipid binding; GO:0005737 cytoplasm; GO:0006916 anti-apoptosis; GO:0050819 negative regulation of coagulation
Regulatory: For research purposes only

Applications of Annexin V Kit

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.

Application Name	Verified	Min Dilution	Max Dilution
Flow Cytometry			Neat

Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.

Instructions For Use: 1) Dilute binding buffer 1:4 in distilled water (50 ml binding buffer + 150 ml distilled water).

2) Wash cells in PBS by gentle shaking or by pipetting up and down.

3) Resuspend cells in 200 ul of pre-diluted binding buffer, adjusting to a cell density of 2-5 x 10⁵ cells/ml.

4) Add 5 ul Annexin V:FITC to 195 ul of the cell suspension prepared in step 3.

5) Mix and incubate for 10 minutes in the dark, at room temperature.

6) Wash cells in 200 ul of pre-diluted binding buffer.

7) Resuspend cells in 190 ul pre-diluted binding buffer.

8) Add 10 ul of the Propidium Iodide solution.

9) Analyse by flow cytometry.

The flow cytometer is preferably set such that the Mean Fluorescence Intensity of the Annexin V negative population is between 1 and 10. Optimal parameter settings can be found using a positive control. For a positive control, incubate the cells with 3% formaldehyde in buffer during 30 minutes on ice. Wash away the formaldehyde and suspend the cells in cold binding buffer at 2-5 x 10⁵ cells/ml. Proceed with step 2 as described above.

Useful Reagents Available

Description	Product Code	Applications	Pack Size	Your Price	Quantity
Annexin V:Biotin Assay Kit	ANNEX100B	F	100 Tests	Log in	Get Quote
Annexin V:FITC Assay Kit	ANNEX100F	F	100 Tests	Log in	Get Quote
Annexin V:Biotin Assay Kit	ANNEX20B	F	20 Tests	Log in	Get Quote
Annexin V:FITC Assay Kit	ANNEX20F	F	20 Tests	Log in	Get Quote

Application Based External Images

Flow Cytometry

Product Specific References

References for Annexin V Kit

Lu, K.H. et al. (2010) In Vitro and In Vivo Apoptosis-Inducing Antileukemic Effects of Mucuna macrocarpa Stem Extract on HL-60 Human Leukemia Cells.
Integr Cancer Ther. 9: 298-308.
Yen, J.H. et al. (2010) Glycine tomentella Hayata inhibits IL-1β and IL-6 production, inhibits MMP-9 activity, and enhances RAW264.7 macrophage clearance of apoptotic cells.
J Biomed Sci. 17: 83.
Chen, C.W. et al. (2010) The signals of FGFs on the neurogenesis of embryonic stem cells.
J Biomed Sci.17:33.
Lu KH et al. (2012) Synergistic Apoptosis-Inducing Antileukemic Effects of Arsenic Trioxide and Mucuna macrocarpa Stem Extract in Human Leukemic Cells via a Reactive Oxygen Species-Dependent Mechanism.
Evid Based Complement Alternat Med. 2012: 921430.
Smith, K. et al. (2011) Mono- and tri-cationic porphyrin-monoclonal antibody conjugates: photodynamic activity and mechanism of action.
Immunology. 132 (2): 256-65.
Koutsogiannaki S et al. (2015) Effects of cadmium and 17β-estradiol on Mytilus galloprovincialis redox status. Prooxidant-antioxidant balance (PAB) as a novel approach in biomonitoring of marine environments.
Mar Environ Res. 103: 80-8.

Fluorescent Spectraviewer

Watch the Tool Tutorial Video ▸

How to Use the Spectraviewer

Watch the Tool Tutorial Video ▸

Start by selecting the application you are interested in, with the option to select an instrument from the drop down menu or create a customized instrument
Select the fluorophores or fluorescent proteins you want to include in your panel to check compatibility
Select the lasers and filters you wish to include
Select combined or multi-laser view to visualize the spectra